The immunogen is a synthetic peptide directed towards the middle region of human RIPK1
Alternative Names:
RIP, RIP1, AIEFL, IMD57, RIP-1
FAK overexpression in human tumors provides a survival signal function by binding to RIP and inhibiting its interaction with the death receptor complex.
Lanes: Lane 1: 10ug 293(Trex)FlpIn-RIPK1-HA-Strep (-Doxycycline)-non induced Lane 2: 10ug 293(Trex)FlpIn-RIPK1-HA-Strep (+Doxycycline)-induced Primary Antibody Dilution: 1:1000 Secondary Antibody: Anti-rabbit HRP Secondary Antibody Dilution: 1:2000 Gene Name: RIPK1 Submitted by: Dr. Tencho Tenev, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research
RIPK1 antibody - middle region (AVARP02038_P050) in Human HepG2 using Western Blot
* VAT and and shipping costs not included. Errors and price changes excepted